Weekly digest
Weekly digest, Oct 19 to Oct 25, 2026: 150 new earnings analyses
Published Oct 25, 2026
150 new earnings analyses (including ORC, SIGI, QS) and 5 market briefs from Oct 19 to Oct 25, 2026.
This week: 150 new earnings analyses and 5 market briefs were published from Oct 19 to Oct 25, 2026. Everything below is taken from those pieces; nothing here is new reporting.
New earnings analyses
| Report | Revenue | Revenue vs. a year earlier | Diluted EPS | EPS vs. a year earlier |
|---|---|---|---|---|
| ORC Q3 2026 | $164M | +51.4% | -$0.90 | n/a |
| SIGI Q3 2026 | $1.3B | -2.5% | $2.11 | +14.1% |
| QS Q3 2026 | $0K | n/a | -$0.14 | n/a |
| IART Q3 2026 | $411M | +2.3% | $0.19 | n/a |
| KRC Q3 2026 | $272M | -2.9% | $0.13 | -90.1% |
| HTH Q3 2026 | $310M | -6.3% | $0.44 | -40.5% |
| HCSG Q3 2026 | $480M | +3.3% | $0.36 | -39.0% |
| FPH Q3 2026 | $15M | +8.4% | -$0.04 | -114.3% |
| BMI Q3 2026 | $236M | +0.1% | $1.24 | +4.2% |
| BCPC Q3 2026 | $291M | +8.6% | $1.46 | +17.7% |
| RNG Q3 2026 | $676M | +5.9% | $6.50 | +3321.1% |
| BAH Q3 2026 | $2.8B | -3.9% | $1.50 | +5.6% |
| AYI Full Year 2026 | $4.6B | +6.8% | $17.05 | +36.1% |
| EAF Q3 2026 | $140M | -2.7% | -$1.76 | -60.0% |
| FAF Q3 2026 | $2.1B | +5.3% | $1.72 | -6.5% |
| ALV Q3 2026 | $2.7B | -0.5% | $2.13 | -6.8% |
| MHO Q3 2026 | $1.1B | -4.9% | $2.56 | -34.7% |
| EONR Q2 2026 | $6.5M | +40.0% | -$0.01 | n/a |
| COCO Q3 2026 | $244M | +33.7% | $0.58 | +45.0% |
| APPF Q3 2026 | $296M | +18.6% | $1.29 | +38.7% |
| NEM Q3 2026 | $6.4B | +15.2% | $2.35 | +40.7% |
| FIX Q3 2026 | $3.8B | +53.7% | $13.91 | +68.6% |
| VRSN Q3 2026 | $443M | +5.7% | $2.35 | +3.5% |
| WDC Q1 2027 | $4.4B | +55.5% | $4.63 | +50.8% |
| DECK Q2 2027 | $1.5B | +3.5% | $2.31 | +26.9% |
| SLB Q3 2026 | $9.4B | +5.8% | $0.49 | -2.0% |
| OMC Q3 2026 | $6.4B | +59.1% | $2.38 | +36.0% |
| AXP Q3 2026 | $20.1B | +8.9% | $5.42 | +30.9% |
| RLI Q3 2026 | $477M | -6.3% | $0.88 | -34.8% |
| WGO Full Year 2026 | $2.7B | -3.4% | $1.21 | +33.0% |
| MLI Q3 2026 | $1.4B | +31.6% | $1.00 | +6.4% |
| HXL Q3 2026 | $496M | +8.8% | $0.50 | +92.3% |
| GGG Q3 2026 | $586M | +7.9% | $0.75 | -8.5% |
| WCN Q3 2026 | $2.6B | +7.3% | $1.43 | +28.8% |
| CACI Q1 2027 | $2.5B | +8.2% | $5.84 | +3.7% |
| AAL Q3 2026 | $16.3B | +19.3% | -$0.41 | n/a |
| TCBI Q3 2026 | $357M | +4.8% | $2.28 | +4.6% |
| MOH Q3 2026 | $11.1B | -3.4% | $0.73 | -51.7% |
| URI Q3 2026 | $4.9B | +15.7% | $14.77 | +35.4% |
| DOW Q3 2026 | $11.3B | +13.0% | $0.62 | +675.0% |
Biggest swings in revenue
Year-over-year revenue change as reported in each analysis, among this week's reports.
Fastest growth
- DNTH Q2 2026: revenue +294.3%
- OMC Q3 2026: revenue +59.1%
- WDC Q1 2027: revenue +55.5%
Slowest growth or decline
- EONR Q1 2026: revenue -78.5%
- DOMH Q2 2026: revenue -56.9%
- TFC Q3 2026: revenue -27.8%
What the analyses found
- ORC Q3 2026 (Revenue $164M (+51.4%) · EPS -$0.90): Orchid Island Capital lost $0.90 a share in Q3 2026 as a jump in rates cut book value per share 17% to $6.02, even though net interest income more than doubled to $59.1M.
- SIGI Q3 2026 (Premiums written $1.1B (-7.0%) · Combined ratio 96.8% · EPS $2.11 (+14.1%)): Selective Insurance’s Q3 2026 combined ratio improved to 96.8% from 98.6% and EPS rose 14% to $2.11, mostly because last year’s $40M reserve charge didn’t recur, while net premiums written fell 7% as it sheds weaker business.
- QS Q3 2026 (Revenue $0K · EPS -$0.14): QuantumScape had no revenue and narrowed its Q3 2026 net loss 20% to $84.5M, mostly through lower non-cash charges; it held $819.8M in cash and investments, and PowerCo paused milestone payments while the two renegotiate.
- IART Q3 2026 (Revenue $411M (+2.3%) · EPS $0.19): Integra's Q3 2026 revenue rose 2.3% to $411.2M despite a ~$7M hit from a flooded Cincinnati plant; GAAP EPS of $0.19 (vs. -$0.07) leaned on one-off other income, while cash flow from operations more than doubled to $96.0M.
- KRC Q3 2026 (Revenue $272M (-2.9%) · EPS $0.13 (-90.1%)): Kilroy Realty's Q3 2026 FFO fell 19.9% to $104.6M as asset sales cut rent and its 7%-occupied Oyster Point campus stopped capitalizing interest; EPS fell to $0.13 from $1.31, mostly on a $110.5M prior-year sale gain.
- HTH Q3 2026 (Net interest income $122M (+8.9%) · NIM 3.33% · EPS $0.44 (-40.5%)): Hilltop Holdings earned $0.44 a share in Q3 2026, down from $0.74, as a widening bank margin (3.33%) was outweighed by a slump in broker-dealer housing revenue, a $10.2M credit-loss provision and bigger mortgage losses.
- HCSG Q3 2026 (Revenue $480M (+3.3%) · EPS $0.36 (-39.0%)): Healthcare Services Group's Q3 2026 revenue rose 3.3% to $479.6M; net income fell 42% to $24.9M only because last year held a $34.2M tax-credit windfall, while both segments widened margins and Q4 revenue is guided to $535–545M after the NEXDINE deal.
- FPH Q3 2026 (Revenue $15M (+8.4%) · EPS -$0.04 (-114.3%)): Five Point swung to a .6M Q3 loss as the Great Park Venture closed no land sales (vs 73M a year ago), while Hearthstone fees lifted revenue 8.4% and management warned some Q4 land sales may be deferred.
- BMI Q3 2026 (Revenue $236M (+0.1%) · EPS $1.24 (+4.2%)): Badger Meter's Q3 2026 sales were flat at $235.9M (down ~2% excluding the UDlive acquisition), but a richer software mix lifted gross margin to 41.9% and buybacks helped diluted EPS rise 4.2% to $1.24.
- BCPC Q3 2026 (Revenue $291M (+8.6%) · EPS $1.46 (+17.7%)): Balchem's Q3 2026 sales rose 8.6% to $290.7M and EPS 17.7% to $1.46, as Human Nutrition sold 12.7% more at 4.4% lower prices; a one-off legal gain flattered margins and inventory is up 35% since December.
- RNG Q3 2026 (Revenue $676M (+5.9%) · EPS $6.50 (+3321.1%)): RingCentral grew Q3 2026 revenue 5.9% to $676.0M and lifted GAAP operating margin to 8.0%; its $6.50 EPS is mostly a one-off $544.9M tax gain ($0.28 without it), while free cash flow rose 21% and full-year guidance was raised.
- BAH Q3 2026 (Revenue $2.8B (-3.9%) · EPS $1.50 (+5.6%)): Booz Allen's revenue fell 3.9% to $2.78B in fiscal Q2 2027 (Jul-Sep 2026) as civil revenue dropped 15%; EPS rose 5.6% to $1.50 only because the tax rate fell to 9%, while adjusted EPS guidance was raised to $6.50-$6.70.
Plus 138 more on the latest reports page.
Market briefs this week
- Treasury yields dive; Amex, Bloom Energy results – Market Brief, Oct 23, 2026: Treasury yields posted their biggest drop since 2023 as tech slid, while American Express and Balchem filed results and Bloom Energy beat estimates.
- P&G, Comcast report; Barclays cuts 5,000 jobs – Market Brief, Oct 22, 2026: Procter & Gamble, Comcast, Blackstone and American Airlines filed quarterly results, while Barclays said it is cutting 5,000 jobs as it leans on AI.
- AT&T fiber gains; Thermo Fisher, Elevance file – Market Brief, Oct 21, 2026: AT&T reported third-quarter results with growth in fiber internet customers, while Thermo Fisher, Elevance Health, CME Group and Chubb filed earnings.
- GM, RTX, 3M report; AI data-center doubts grow – Market Brief, Oct 20, 2026: General Motors, RTX, 3M, Halliburton and Synchrony filed quarterly results, while AI data-center listings stalled and the SEC set a November data roundtable.
- Fifth Third, Jefferies file; JPMorgan defense push – Market Brief, Oct 19, 2026: Fifth Third posts quarterly results in an 8-K, Jefferies files a Regulation FD disclosure, and JPMorgan details $5 billion of defense investments.
Assembled automatically each week from this site's own published analyses and briefs. Figures are as stated in each linked report. For information only; not investment advice.
Related analyses
- Orchid Island Capital, Inc. (ORC) · Q3 2026Revenue $164M (+51.4%) · EPS -$0.90
Orchid Island Capital lost $0.90 a share in Q3 2026 as a jump in rates cut book value per share 17% to $6.02, even though net interest income more than doubled to $59.1M.
- Selective Insurance Group, Inc. (SIGI) · Q3 2026Premiums written $1.1B (-7.0%) · Combined ratio 96.8% · EPS $2.11 (+14.1%)
Selective Insurance’s Q3 2026 combined ratio improved to 96.8% from 98.6% and EPS rose 14% to $2.11, mostly because last year’s $40M reserve charge didn’t recur, while net premiums written fell 7% as it sheds weaker business.
- QuantumScape Corporation (QS) · Q3 2026Revenue $0K · EPS -$0.14
QuantumScape had no revenue and narrowed its Q3 2026 net loss 20% to $84.5M, mostly through lower non-cash charges; it held $819.8M in cash and investments, and PowerCo paused milestone payments while the two renegotiate.
- Integra LifeSciences Holdings Corporation (IART) · Q3 2026Revenue $411M (+2.3%) · EPS $0.19
Integra's Q3 2026 revenue rose 2.3% to $411.2M despite a ~$7M hit from a flooded Cincinnati plant; GAAP EPS of $0.19 (vs. -$0.07) leaned on one-off other income, while cash flow from operations more than doubled to $96.0M.
For information only; not investment advice.